University of California, Berkeley, B.A., Molecular and Cell Biology, 1997
University of California, Davis, M.D., Medicine, 2004
2004-2005 University of Nebraska, Intern, General Surgery
2005-2009 University of Nebraska, Resident, General Surgery
2010-2012 Mayo Clinic, Resident, Plastic Surgery
2012-2013 University of California, San Francisco, Microsurgery Fellowship
American Board of Surgery, General Surgery
American Board of Plastic Surgery
Botox and Fillers
General Plastic & Reconstructive Surgery
Microvascular Breast Reconstruction
Post-Bariatric Body Contouring
Skin Cancer Reconstruction
Coagulopathy in microvascular surgery
Composite allograft tissue transfer
Esther A. Kim, M.D. is a native of California and a graduate of UC Berkeley and UC Davis School of Medicine. She participated in basic science research throughout her years at UC Berkeley and winning a research grant she dedicated an extra year during her medical school studying pro-apoptotic molecules in cancer. After graduating from medical school in 2004, she pursued general surgery training at UNMC, graduating in 2009. Thereafter, she completed her Plastic Surgery Residency at the Mayo Clinic and a Microsurgery fellowship at UCSF. She joined the faculty in the Division of Plastic and Reconstructive Surgery in 2013. Her practice includes both reconstructive plastic surgery and cosmetic surgery. She specializes in microvascular reconstructive surgery with emphasis in post-mastectomy breast reconstruction and complex lower extremity wounds. Her cosmetic practice includes oculoplastics, Asian blepharoplasty and Post-Bariatric body contouring. Dr. Kim is also developing a multidisciplinary transgender surgery program at SFGH.
Dr. Kim's research focuses on understanding coagulopathy in patients undergoing microvascular surgery. Her research aims to improve overall surgical outcomes and decrease complications in microvascular surgery. Her other interests include composite allograft tissue transfer and wound healing.
Xin H, Stephans JC, Duan X, Harrowe G, Kim E, Grieshammer U, Kingsley C, Giese K. Identification of a novel aspartic-like protease differentially expressed in human breast cancer cell lines. Biochim Biophys Acta. 2000 Jun 15; 1501(2-3):125-37. View in PubMed
Chiu CY, Leng S, Martin KA, Kim E, Gorman S, Duhl DM. Cloning and characterization of T-cell lymphoma invasion and metastasis 2 (TIAM2), a novel guanine nucleotide exchange factor related to TIAM1. Genomics. 1999 Oct 1; 61(1):66-73. View in PubMed
Gorman SW, Haider NB, Grieshammer U, Swiderski RE, Kim E, Welch JW, Searby C, Leng S, Carmi R, Sheffield VC, Duhl DM. The cloning and developmental expression of unconventional myosin IXA (MYO9A) a gene in the Bardet-Biedl syndrome (BBS4) region at chromosome 15q22-q23. Genomics. 1999 Jul 15; 59(2):150-60. View in PubMed
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.